Metzger Michael A 4
4 · Syndax Pharmaceuticals Inc · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Metzger Michael A
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-02-10$15.50/sh−13,288$206,017→ 300,121 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.